Literature DB >> 25088941

Cetuximab or bevacizumab in metastatic colorectal cancer?

Francesco Sclafani1, David Cunningham2.   

Abstract

Entities:  

Mesh:

Substances:

Year:  2014        PMID: 25088941     DOI: 10.1016/S1470-2045(14)70360-2

Source DB:  PubMed          Journal:  Lancet Oncol        ISSN: 1470-2045            Impact factor:   41.316


× No keyword cloud information.
  5 in total

Review 1.  Targeted therapy in first line treatment of RAS wild type colorectal cancer.

Authors:  Vincenzo Formica; Mario Roselli
Journal:  World J Gastroenterol       Date:  2015-03-14       Impact factor: 5.742

2.  Colorectal liver metastases are more often super wild type. Toward treatment based on metastatic site genotyping?

Authors:  M A Allard; R Saffroy; P Bouvet de la Maisonneuve; L Ricca; N Bosselut; J Hamelin; E Lecorche; M A Bejarano; P Innominato; M Sebagh; R Adam; J F Morère; A Lemoine
Journal:  Target Oncol       Date:  2014-11-26       Impact factor: 4.493

3.  Mass Cytometry Reveals a Sustained Reduction in CD16+ Natural Killer Cells Following Chemotherapy in Colorectal Cancer Patients.

Authors:  Diana Shinko; Helen M McGuire; Connie I Diakos; Nick Pavlakis; Stephen J Clarke; Scott N Byrne; Kellie A Charles
Journal:  Front Immunol       Date:  2019-11-05       Impact factor: 7.561

4.  Sequential therapy with bevacizumab and EGFR inhibitors for metastatic colorectal carcinoma: a national registry-based analysis.

Authors:  Tomas Buchler; Renata Chloupkova; Alexandr Poprach; Ondrej Fiala; Igor Kiss; Katerina Kopeckova; Ladislav Dusek; Veronika Veskrnova; Lubomir Slavicek; Milan Kohoutek; Jindrich Finek; Marek Svoboda; Lubos Petruzelka; Bohuslav Melichar
Journal:  Cancer Manag Res       Date:  2018-12-28       Impact factor: 3.989

5.  Combined Analysis of EGFR and PTEN Status in Patients With KRAS Wild-Type Metastatic Colorectal Cancer.

Authors:  Yu Chen; Yi Shi; Jing Lin; Yun-Bin Ye; Xiao-Jie Wang; Gang Chen; Zeng-Qing Guo
Journal:  Medicine (Baltimore)       Date:  2015-10       Impact factor: 1.817

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.